Cargando…
Metabolomics for biomarker discovery in the diagnosis, prognosis, survival and recurrence of colorectal cancer: a systematic review
Colorectal cancer (CRC) remains an incurable disease. There are no effective noninvasive techniques that have achieved colorectal cancer (CRC) diagnosis, prognosis, survival and recurrence in clinic. To investigate colorectal cancer metabolism, we perform an electronic literature search, from 1998 t...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471069/ https://www.ncbi.nlm.nih.gov/pubmed/28389626 http://dx.doi.org/10.18632/oncotarget.16727 |
_version_ | 1783243882979393536 |
---|---|
author | Zhang, Fan Zhang, Yuanyuan Zhao, Weiwei Deng, Kui Wang, Zhuozhong Yang, Chunyan Ma, Libing Openkova, Margarita S. Hou, Yan Li, Kang |
author_facet | Zhang, Fan Zhang, Yuanyuan Zhao, Weiwei Deng, Kui Wang, Zhuozhong Yang, Chunyan Ma, Libing Openkova, Margarita S. Hou, Yan Li, Kang |
author_sort | Zhang, Fan |
collection | PubMed |
description | Colorectal cancer (CRC) remains an incurable disease. There are no effective noninvasive techniques that have achieved colorectal cancer (CRC) diagnosis, prognosis, survival and recurrence in clinic. To investigate colorectal cancer metabolism, we perform an electronic literature search, from 1998 to January 2016, for studies evaluating the metabolomic profile of patients with CRC regarding the diagnosis, recurrence, prognosis/survival, and systematically review the twenty-three literatures included. QUADOMICS tool was used to assess the quality of them. We highlighted the metabolism perturbations based on metabolites and pathway. Metabolites related to cellular respiration, carbohydrate, lipid, protein and nucleotide metabolism were significantly altered in CRC. Altered metabolites were also related to prognosis, survival and recurrence of CRC. This review could represent the most comprehensive information and summary about CRC metabolism to date. It certificates that metabolomics had great potential on both discovering clinical biomarkers and elucidating previously unknown mechanisms of CRC pathogenesis. |
format | Online Article Text |
id | pubmed-5471069 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-54710692017-06-27 Metabolomics for biomarker discovery in the diagnosis, prognosis, survival and recurrence of colorectal cancer: a systematic review Zhang, Fan Zhang, Yuanyuan Zhao, Weiwei Deng, Kui Wang, Zhuozhong Yang, Chunyan Ma, Libing Openkova, Margarita S. Hou, Yan Li, Kang Oncotarget Review Colorectal cancer (CRC) remains an incurable disease. There are no effective noninvasive techniques that have achieved colorectal cancer (CRC) diagnosis, prognosis, survival and recurrence in clinic. To investigate colorectal cancer metabolism, we perform an electronic literature search, from 1998 to January 2016, for studies evaluating the metabolomic profile of patients with CRC regarding the diagnosis, recurrence, prognosis/survival, and systematically review the twenty-three literatures included. QUADOMICS tool was used to assess the quality of them. We highlighted the metabolism perturbations based on metabolites and pathway. Metabolites related to cellular respiration, carbohydrate, lipid, protein and nucleotide metabolism were significantly altered in CRC. Altered metabolites were also related to prognosis, survival and recurrence of CRC. This review could represent the most comprehensive information and summary about CRC metabolism to date. It certificates that metabolomics had great potential on both discovering clinical biomarkers and elucidating previously unknown mechanisms of CRC pathogenesis. Impact Journals LLC 2017-03-30 /pmc/articles/PMC5471069/ /pubmed/28389626 http://dx.doi.org/10.18632/oncotarget.16727 Text en Copyright: © 2017 Zhang et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) (CC-BY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Review Zhang, Fan Zhang, Yuanyuan Zhao, Weiwei Deng, Kui Wang, Zhuozhong Yang, Chunyan Ma, Libing Openkova, Margarita S. Hou, Yan Li, Kang Metabolomics for biomarker discovery in the diagnosis, prognosis, survival and recurrence of colorectal cancer: a systematic review |
title | Metabolomics for biomarker discovery in the diagnosis, prognosis, survival and recurrence of colorectal cancer: a systematic review |
title_full | Metabolomics for biomarker discovery in the diagnosis, prognosis, survival and recurrence of colorectal cancer: a systematic review |
title_fullStr | Metabolomics for biomarker discovery in the diagnosis, prognosis, survival and recurrence of colorectal cancer: a systematic review |
title_full_unstemmed | Metabolomics for biomarker discovery in the diagnosis, prognosis, survival and recurrence of colorectal cancer: a systematic review |
title_short | Metabolomics for biomarker discovery in the diagnosis, prognosis, survival and recurrence of colorectal cancer: a systematic review |
title_sort | metabolomics for biomarker discovery in the diagnosis, prognosis, survival and recurrence of colorectal cancer: a systematic review |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471069/ https://www.ncbi.nlm.nih.gov/pubmed/28389626 http://dx.doi.org/10.18632/oncotarget.16727 |
work_keys_str_mv | AT zhangfan metabolomicsforbiomarkerdiscoveryinthediagnosisprognosissurvivalandrecurrenceofcolorectalcancerasystematicreview AT zhangyuanyuan metabolomicsforbiomarkerdiscoveryinthediagnosisprognosissurvivalandrecurrenceofcolorectalcancerasystematicreview AT zhaoweiwei metabolomicsforbiomarkerdiscoveryinthediagnosisprognosissurvivalandrecurrenceofcolorectalcancerasystematicreview AT dengkui metabolomicsforbiomarkerdiscoveryinthediagnosisprognosissurvivalandrecurrenceofcolorectalcancerasystematicreview AT wangzhuozhong metabolomicsforbiomarkerdiscoveryinthediagnosisprognosissurvivalandrecurrenceofcolorectalcancerasystematicreview AT yangchunyan metabolomicsforbiomarkerdiscoveryinthediagnosisprognosissurvivalandrecurrenceofcolorectalcancerasystematicreview AT malibing metabolomicsforbiomarkerdiscoveryinthediagnosisprognosissurvivalandrecurrenceofcolorectalcancerasystematicreview AT openkovamargaritas metabolomicsforbiomarkerdiscoveryinthediagnosisprognosissurvivalandrecurrenceofcolorectalcancerasystematicreview AT houyan metabolomicsforbiomarkerdiscoveryinthediagnosisprognosissurvivalandrecurrenceofcolorectalcancerasystematicreview AT likang metabolomicsforbiomarkerdiscoveryinthediagnosisprognosissurvivalandrecurrenceofcolorectalcancerasystematicreview |